MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Irinotecan

CAS No. : 97682-44-5

MCE 站：Irinotecan

产品活性：Irinotecan ((+)-Irinotecan) 是一种拓扑异构酶 I (topoisomerase I) 抑制剂，可用于结肠癌和直肠癌的研究。

研究领域：Cell Cycle/DNA Damage  |  Autophagy

作用靶点：Topoisomerase  |  Autophagy

In Vitro: Irinotecan is a topoisomerase I inhibitor. Irinotecan inhibits the growth of LoVo and HT-29 cells, with IC₅₀s of 15.8 ± 5.1 and 5.17 ± 1.4 μM, respectively, and induces similar amounts of cleavable complexes in both in LoVo and HT-29 cells. Irinotecan suppresses the proliferation of human umbilical vein endothelial cells (HUVEC), with an IC₅₀ of 1.3 μM.

In Vivo: Irinotecan (CPT-11, 5 mg/kg) significantly inhibits the growth of tumors by intratumoral injection daily for 5 days, on two consecutive weeks in rats, and such effects also occur via continuous intraperitoneal infusion by osmotic minipump into mice. However, Irinotecan (10 mg/kg) shows no effect on the growth of tumor by i.p. Irinotecan (CPT-11, 100-300 mg/kg, i.p.) apparently suppresses tumor growth of HT-29 xenografts in athymic female mice by day 21. The two groups of Irinotecan (125 mg/kg) plus TSP-1 (10 mg/kg per day) or Irinotecan (150 mg/kg) in combination TSP-1 (20 mg/kg per day) are nearly equally effective and inhibit tumor growth 84% and 89%, respectively, and both are more effective than Irinotecan alone at doses of 250 and 300 mg/kg.

相关产品：Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  CNS-Penetrant Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Alkaloids Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Doxorubicin hydrochloride  |  Etoposide  |  SN-38  |  Camptothecin  |  Topotecan Hydrochloride  |  Epirubicin hydrochloride  |  Daunorubicin hydrochloride  |  Exatecan mesylate  |  Suramin sodium salt  |  Berberine chloride  |  Irinotecan hydrochloride  |  Mitoxantrone  |  Betulinic acid  |  EIDD-1931  |  Idarubicin hydrochloride  |  Aldoxorubicin  |  Banoxantrone dihydrochloride  |  β-Lapachone  |  Teniposide  |  Hycanthone  |  Pirarubicin  |  Bisantrene  |  Aclacinomycin A hydrochloride  |  Amsacrine  |  Daun02

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。